[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,638,448
  • Shares Outstanding, K 193,574
  • Annual Sales, $ 3,221 M
  • Annual Income, $ 348,900 K
  • EBIT $ 237 M
  • EBITDA $ 312 M
  • 60-Month Beta 0.24
  • Price/Sales 3.94
  • Price/Cash Flow 23.00
  • Price/Book 2.01

Options Overview Details

View History
  • Implied Volatility 38.60% (+2.28%)
  • Historical Volatility 34.65%
  • IV Percentile 33%
  • IV Rank 39.68%
  • IV High 55.46% on 02/23/26
  • IV Low 27.50% on 01/15/26
  • Expected Move (DTE 21) 1.66 (2.58%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 517
  • Volume Avg (30-Day) 1,883
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 34,652
  • Open Int (30-Day) 38,152
  • Expected Range 62.69 to 66.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.18
  • Number of Estimates 7
  • High Estimate $1.28
  • Low Estimate $0.94
  • Prior Year $-0.08
  • Growth Rate Est. (year over year) +1,575.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.89 +9.20%
on 08/06/26
70.98 -9.40%
on 08/12/26
+2.24 (+3.61%)
since 07/28/26
3-Month
53.01 +21.32%
on 06/03/26
70.98 -9.40%
on 08/12/26
+11.57 (+21.94%)
since 05/28/26
52-Week
49.26 +30.55%
on 05/18/26
70.98 -9.40%
on 08/12/26
+6.63 (+11.49%)
since 08/28/25

Most Recent Stories

More News
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)

Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)

BMRN : 64.30 (-1.52%)
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

BMRN : 64.30 (-1.52%)
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline

BioMarin to pay $275 million upfront, plus additional payments upon achievement of development and regulatory milestones

BMRN : 64.30 (-1.52%)
3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky

RH : 148.93 (+2.85%)
BMRN : 64.30 (-1.52%)
FSTR : 37.40 (-1.14%)
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

BMRN : 64.30 (-1.52%)
BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston

SAN RAFAEL, Calif. , Aug. 10, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced management will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday,...

BMRN : 64.30 (-1.52%)
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations

BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations

BMRN : 64.30 (-1.52%)
BioMarin: Q2 Earnings Snapshot

BioMarin: Q2 Earnings Snapshot

BMRN : 64.30 (-1.52%)
BioMarin Reports Second Quarter 2026 Financial and Operating Results

Second Quarter 2026 Total Revenues Increased 20% Year-over-year to $990 million

BMRN : 64.30 (-1.52%)
BioMarin: Can Amicus Integration Costs Justify What You're Now Paying for Growth?

Barchart Research What to Expect from BMRN Earnings BMRN Generated August 5, 2026 Current Price $59.91 EPS Estimate $$0.79 Consensus Rating Moderate Buy Average Move 3.39% BioMarin: Can Amicus Integration...

BMRN : 64.30 (-1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 66.94
2nd Resistance Point 66.43
1st Resistance Point 65.86
Last Price 64.30
1st Support Level 64.78
2nd Support Level 64.26
3rd Support Level 63.69

See More

52-Week High 70.98
Last Price 64.30
Fibonacci 61.8% 62.68
Fibonacci 50% 60.12
Fibonacci 38.2% 57.56
52-Week Low 49.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.